黑料网

Antibiotic resistance, a global public health crisis, extends its ominous shadow not only over human medicine but also over the realm of small animal veterinary care. Small animals, including dogs and cats, have long been cherished companions in households around the world. Yet, as with their human counterparts, these beloved pets are increasingly threatened by the emergence and proliferation of antibiotic-resistant infections. The treatment of such infections in small animals has become an urgent and complex challenge in contemporary veterinary medicine. Antibiotics have historically played a pivotal role in the management of bacterial infections in small animals. These infections, ranging from common skin ailments to life-threatening systemic diseases, have found their match in the curative powers of antibiotics. However, the misuse and overuse of antibiotics in veterinary practice have set the stage for the development of resistance in bacterial pathogens that afflict small animals. This resistance, fuelled by a complex interplay of factors including inappropriate prescribing, inadequate dosing, and suboptimal infection control measures, threatens to erode the effectiveness of antibiotics, leaving veterinarians and pet owners grappling with limited treatment options. This introduction seeks to illuminate the multifaceted challenges posed by antibiotic-resistant infections in small animals. It elucidates the underlying factors contributing to the emergence of resistance and delineates the dire consequences it exacts upon the health and wellbeing of our furry companions. It also underscores the imperative to adopt a comprehensive and collaborative approach, both within the veterinary community and through the broader lens of One Health, to tackle this critical issue. In this era of antibiotic resistance, small animal veterinarians find themselves at a crossroads where judicious antibiotic use, innovative treatment modalities, and antimicrobial stewardship practices converge. The development of novel antibiotics and alternative therapeutic strategies tailored to the unique needs of small animals is imperative. Moreover, educating veterinarians, pet owners, and the public at large about the responsible use of antibiotics is essential to mitigate the further spread of resistance. As we embark on this exploration of the treatment of resistant infections in small animals with antibiotics, we must recognize the gravity of the challenge ahead. We must also acknowledge the profound responsibility we bear in safeguarding the health and welfare of our cherished animal companions. This journey calls for collective action, unwavering commitment to sound veterinary practices, and a steadfast dedication to preserving the efficacy of antibiotics for the benefit of both present and future generations of small animals and the humans who adore them [1-6].

Discussion

The treatment of antibiotic-resistant infections in small animals presents a multifaceted challenge that encompasses clinical, scientific, ethical, and One Health dimensions. This discussion section delves into key aspects of this critical issue and highlights strategies and considerations for effective management.

1. The clinical challenge

A. diagnosis and surveillance: Accurate diagnosis of infections in small animals is paramount. Rapid and precise identification of the causative pathogens and their antibiotic susceptibility profiles can guide treatment decisions. Regular surveillance for antibiotic resistance patterns in veterinary clinics and hospitals is essential to inform empirical therapy choices.

B. alternative treatment modalities: Veterinarians are increasingly exploring alternative treatments, such as phage therapy, immunotherapy, and probiotics, as adjuncts or alternatives to antibiotics. These approaches show promise in some cases but require further research and validation.

C. antibiotic selection: When antibiotics are necessary, choosing the most appropriate drug is crucial. Narrow-spectrum antibiotics and those with less cross-resistance should be favored. Veterinaryspecific antibiotic guidelines can aid practitioners in making informed decisions.

2. The scientific frontier

A. development of novel antibiotics: Research into novel antibiotics tailored for small animal use is imperative. Investment in innovative drug discovery, including bacteriophage-based therapies and antimicrobial peptides, can expand the arsenal of treatment options.

B. combating biofilm formation: Bacterial biofilms are a common cause of chronic and recurrent infections in small animals. Strategies to disrupt or prevent biofilm formation are an active area of research.

3. Ethical considerations

A. balancing pet welfare and antibiotic use: Veterinarians face ethical dilemmas when considering treatment options for antibioticresistant infections. Decisions must prioritize the welfare of the animal while upholding responsible antibiotic use principles.

B. informed consent: Pet owners should be educated about the risks and benefits of antibiotic treatments, including the potential for antibiotic resistance development. Informed consent fosters shared decision-making and responsible antibiotic use.

4. The one health approach:

A. interconnected health: Recognizing the interconnectedness of human, animal, and environmental health is fundamental. The dissemination of antibiotic resistance genes between animals and humans underscores the importance of a One Health perspective.

B. antimicrobial stewardship: Collaborative efforts between veterinarians, physicians, public health officials, and policymakers are essential to implement antimicrobial stewardship programs that promote responsible antibiotic use across all sectors.

5. Public Awareness and Education:

A. owner education: Raising awareness among pet owners about antibiotic resistance, its consequences, and the importance of following prescribed treatment regimens can contribute to responsible antibiotic use in small animals.

6. Regulatory frameworks

Monitoring and reporting: Establishing comprehensive monitoring and reporting systems for antibiotic use and resistance in veterinary medicine can guide interventions and regulatory measures.

7. Future directions

Addressing antibiotic resistance in small animals is an evolving endeavor. Continued research into innovative therapies, the development of robust guidelines, and the integration of antimicrobial stewardship principles into veterinary practice are essential for mitigating the impact of antibiotic resistance on small animals’ health [7-11].

Conclusion

The treatment of antibiotic-resistant infections in small animals stands at the crossroads of clinical necessity, scientific innovation, ethical responsibility, and global interconnectedness. It is a challenge that demands our unwavering commitment to responsible antibiotic use, a dedication to research-driven solutions, and recognition of the profound impact it has on the health and well-being of our cherished animal companions. In this discussion, we have explored the clinical aspects of diagnosis, treatment, and the judicious selection of antibiotics. We have recognized the critical need for alternative treatment modalities and the exploration of new antibiotics tailored for small animal use. In conclusion, the treatment of antibiotic-resistant infections in small animals is a multifaceted challenge that requires a multifaceted response. By navigating this challenge with compassion, scientific rigor, and a One Health perspective, we can aspire to preserve the health and well-being of our beloved small animal companions while safeguarding the effectiveness of antibiotics for generations to come. The path forward is clear: responsible stewardship, innovative solutions, and a shared commitment to the welfare of our small animal companions and the health of our shared global community.

Acknowledgment

None

Conflict of Interest

None

1. Meyer A, Holt HR, Oumarou F, Chilongo K, Gilbert W, et al. (2018)Parasites and Vectors 11:1–14.

, ,

2. Tekle T, Terefe G, Cherenet T, Ashenafi H, Akoda KG, et al. (2018)BMC Vet Res 14: 4.

, ,

3. Shaw APM, Wintd B GC, GRW, Mattiolie RC, Robinson TP, et al. (2014)Prev Vet Med 113:197–210.

, ,

4. Romano M,Portela DA,Thomson A,Otero PE (2021)Vet Anaesth Analg 48:101–106.

, ,

5. Holopherne-Doran D,Laboissière B,Gogny M (2010)Vet Anaesth Anal37:10.

, ,

6. Shaw A, Wint W, Cecchi G, Torr S, Waiswa C, et al. (2017)Food and Agriculture Organization of the United Nations PAAT Technical and Scientific Series.

,

7. Pelin Z,Kaner T (2012)Neurol Int.4:18.

Indexed at, ,

8. Sturiale CL,Massimi L,Mangiola A,Pompucci A,Roselli R,et al. (2010)Neurosurgery67:E1170–9.

, ,

9. Theyse LFH, Van de Brom WE, Van Sluijs FJ (1998)Veterinary Record 143:48-50.

, ,

10. Raghavan M, Glickman NW, Glickman LT (2006)Journal of the American Animal Hospital Association 42:28-36.

, ,

11. Beck JJ, Staatz AJ, Pelsue DH, Kudnig ST, MacPhail CM , et al. (2006)Journal of the American Veterinary Medical Association 229:1934-1939.

, ,